News


Prosafe SE: Q4 2017 - presentation material

Tuesday , 06 February 2018

Please find attached the presentation of the Q4 2017 results. Jesper K. Andresen, CEO and Stig H. Christiansen, Deputy CEO and CFO will go through the presentation during a webcast at 10:00 a.m. CET today. To follow the presentation, please go to www.prosafe.com and click on the "Webcast" link at the bottom of the front page. To listen to the webcast from the web, you need to have installed Windows Media Player and have a sound card on your computer. It will be possible to...

READ MORE...


INTERIM REPORT FOR THE PERIOD 1 JULY 2017 TO 31 DECEMBER 2017

Tuesday , 06 February 2018

Consolidated revenue for H1 2017/18 amounted to DKK 1,483 million (DKK 1,517 million) corresponding to a reduction of 2.2% (1.5% measured in local currency). Revenue decreased in the wholesale channel whereas the retail channel reported increased revenue. The gross margin increased by 1.3% to 57.9% compared to the same period last financial year. Costs decreased by DKK 26 million, and the cost ratio was improved by 44.0% (44.7%). The consolidated operating profit for H1 2017/18 amounted to DKK 2...

READ MORE...


Invitation to 2017 Results Presentation in Oslo

Tuesday , 06 February 2018

DNO ASA will release its 2017 results to the Oslo Stock Exchange at 08:00 am CET on 8 February 2018. A management presentation will follow at Felix 1, Felix Konferansesenter, Bryggetorget 3, Aker Brygge, 0125 Oslo at 10:00 am CET. A live webcast of the presentation will be available on www.dno.no and an archived version of the webcast will be posted on the Company's website. The presentation will be in English. Oslo, 6 February 2018 This information is subject to the discl...

READ MORE...


Alliance Trust PLC : Transaction in Own Shares

Tuesday , 06 February 2018

TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 5 February 2018 the Company purchased for cancellation 157,567 ordinary shares of 2.5p each at a price of 738.845p per share.  Therefore, the total number of voting rights in the Company is now 347,234,589.      The above figure (347,234,589) may be used by shareholders as the denominator for the calculations by which they will determine if they are require...

READ MORE...


Ahold Delhaize share buyback update

Tuesday , 06 February 2018

Zaandam, the Netherlands, February 6, 2018 - Ahold Delhaize has repurchased 2,891,287 of Ahold Delhaize common shares in the period from January 29, 2018 up to and including February 2, 2018. The shares were repurchased at an average price of €17.99 per share for a total consideration of €52 million. These repurchases were made as part of the €2 billion share buyback program announced on November 8, 2017. The total number of shares repurchased under this program to date is...

READ MORE...


Crossword Cybersecurity plc - Trading Statement

Tuesday , 06 February 2018

Crossword Cybersecurity Plc (NEX: CCS)("Crossword"), the technology commercialisation Company focusing exclusively on the cyber security sector, announces a trading statement today for the financial year ended 31 December 2017. Full year results for the year are expected to be announced by the end of April 2018. Crossword's revenue for the financial year to 31 December 2017 is expected to show an increase of over 110% when compared to the financial year 2016. Crossword's ...

READ MORE...


Galantas Updates on Planning Appeal on Omagh Gold Mine

Tuesday , 06 February 2018

TORONTO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSXV:GAL) (AIM:GAL) (the “Company”), the AIM and TSXV quoted gold producer and explorer with a 100% interest in Northern Ireland’s Omagh gold mine, announces a date change for the third party appeal against a positive Judicial review of its planning consent. Due to illness of the third party, who is a litigant in person, the date of the hearing of the appeal has been postponed until February 15, 2018....

READ MORE...


Robocath sets up medical advisory board composed of international interventional cardiology key lead

Tuesday , 30 January 2018

Rouen, January 30, 2018 – Robocath, a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases, announces today the creation of its medical advisory board, including global experts and recognized leaders in interventional cardiology. This committee will help define the clinical strategy of the company and more broadly contribute to the development of future generations of Robocath’s robotic system products. Philippe Bencteux...

READ MORE...


Zealand Pharma hosts Capital Market Day: Accelerating the late stage pipeline

Thursday , 25 January 2018

Press release - No. 2/2017 Zealand Pharma hosts Capital Market Day: Accelerating the late stage pipeline    Four late stage programs with best-in-class potential and attractive risk profiles for rare diseases and diabetes   Ambition to become a world leader in specialty gastrointestinal and metabolic diseases has been established Copenhagen 25 January, 2018 - Zealand Pharma (Zealand) will host a Capital Market Day in New York, starting at 12:30 pm ET (6...

READ MORE...


BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Onc

Friday , 26 January 2018

NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, announced that the Company presented data from several studies of its lead asset, Plinabulin, at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium. The Phase 2 portion of its global Phase 2/3 clinical trial (Study 105) for the prevention of docetaxel chemotherapy-induced neutropenia ...

READ MORE...


Featured Employers

© 2018 Jobsinpharma - 4ward Technologies Ltd All rights reserved.